Mon–Thu 8am–4:30pm CT · Fri 8am–3pm CT
Clinical Trial · NCT05814835
Overview
This is the first-in-human study of 68Ga/64Cu-FAPI-XT117, which is an prospective, single-arm phase I clinical study.
Sponsor
Chinese PLA General Hospital
Phase
Phase 1
Contacts
Zhihui Shen
shenzhihui301@126.com
010-66936793
ClinicalTrials.gov
NCT05814835Help us improve your experience